Matthew Capehorn
- Endocrinology, Diabetes and Metabolism top 1%
- Molecular Biology
- Pharmacology top 5%
- Surgery
- Physiology
- Co-authors
- Anders G. HolstIldiko LingvayVanita R. ArodaG. CharpentierAndrew AhmannMiriam AnnettElena HenkelFrancesco Dotta
- Topics
- Diabetes Treatment and Management (19 papers)Metabolism, Diabetes, and Cancer (14 papers)Diabetes Management and Research (7 papers)
- Journals
- Journal of the American College of CardiologyThe Journal of Clinical Endocrinology & MetabolismDiabetes Care
- Partner nations
- United KingdomDenmarkUnited States
In The Last Decade
Matthew Capehorn
33 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Endocrinology, Diabetes and Metabolism 965
- Molecular Biology 600
- Pharmacology 273
- Surgery 263
- Physiology 150
Countries citing papers authored by Matthew Capehorn
This map shows the geographic impact of Matthew Capehorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Capehorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Capehorn more than expected).
Fields of papers citing papers by Matthew Capehorn
This network shows the impact of papers produced by Matthew Capehorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Capehorn. The network helps show where Matthew Capehorn may publish in the future.
Co-authorship network of co-authors of Matthew Capehorn
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Capehorn. A scholar is included among the top collaborators of Matthew Capehorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Capehorn. Matthew Capehorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 43 | |
| 6 | 39 | |
| 7 | 7 | |
| 8 | 22 | |
| 9 | 5 | |
| 10 | 19 | |
| 11 | 10 | |
| 12 | 1 | |
| 13 | 45 | |
| 14 | Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)breakdown → | 283 |
| 15 | 14 | |
| 16 | 13 | |
| 17 | 4 | |
| 18 | 41 | |
| 19 | 24 | |
| 20 | Public health. Catching up with the obesity crisis. | 1 |
About Matthew Capehorn
Matthew Capehorn is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacy and Family Practice, having authored 35 papers that have together received 1.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (19 papers), Metabolism, Diabetes, and Cancer (14 papers) and Diabetes Management and Research (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (965 citations), Pharmacology (273 citations) and Pharmacy (70 citations). Matthew Capehorn has collaborated with scholars based in United Kingdom, Denmark and United States. Frequent co-authors include Anders G. Holst, Ildiko Lingvay, Vanita R. Aroda, G. Charpentier, Andrew Ahmann, Miriam Annett, Elena Henkel, Francesco Dotta, Andrei‐Mircea Catarig and Andrej Janež. Their work appears in journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.